Physician profile
John Mcgill
NPI 1982847703
$29,732.86
in general payments reported to CMS, 2019-2025
23 companies · $26K in 2025
The $26K reported for 2025 was more than what 97% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $279 · 2021: $244 · 2022: $237 · 2023: $341 · 2024: $1,888 · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Travel and Lodging: $7,739 · Food and Beverage: $1,661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,080.00 |
| Travel and Lodging | $7,738.67 |
| Food and Beverage | $1,660.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $25,663.09 | 2025 | Keytruda |
| Boston Scientific Corporation | $1,829.54 | 2019-2024 | Rezum Generator, Xpeeda Dsl Fiber, Spaceoar Vue System - 10ml |
| Astellas Pharma US INC | $550.49 | 2019-2023 | Veozah |
| Intuitive Surgical, INC. | $454.96 | 2025 | |
| Procept Biorobotics Corporation | $297.35 | 2024 | Aquabeam System |
| Sumitomo Pharma America, INC. | $142.79 | 2023 | Gemtesa |
| Allergan, INC. | $114.07 | 2019-2021 | |
| Progenics Pharmaceuticals, INC. | $103.19 | 2023 | Pylarify |
| Abbvie INC. | $102.39 | 2022-2025 | |
| Endo Pharmaceuticals INC. | $85.65 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $82.97 | 2019 | |
| Laborie Medical Technologies Corp. | $62.32 | 2024-2025 | Endosheath Technology, Urgent PC Neuromodulation System, Optilume Bph Drug Coated Balloon Catheter |
| Medtronic, INC. | $47.29 | 2025 | Interstim |
| Coloplast Corp | $36.57 | 2020-2022 | |
| Photocure INC | $23.21 | 2025 | Cysview |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sagent Pharmaceuticals | $21.44 | 2019 | |
| Sun Pharmaceutical Industries INC. | $21.30 | 2024 | |
| Myriad Genetic Laboratories, INC. | $20.16 | 2023 | Prolaris |
| Olympus America INC. | $17.28 | 2025 | Itind System |
| Medtronic USA, INC. | $16.92 | 2020 | |
| Avadel Specialty Pharmaceuticals, LLC | $13.56 | 2019 | |
| Ambu INC. | $13.28 | 2021 | |
| Pfizer INC. | $13.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mcgill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.